STOCK TITAN

Maplight Therapeutics (MPLT) Form 144 lists RSU grants and broker info

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Maplight Therapeutics, Inc. submitted a Form 144 notice related to proposed sales of Common stock, filed with a broker address listed as Jefferies, 520 Madison Ave, New York. The filing date shown is 04/15/2026. The excerpt lists prior Restricted Stock Unit grants of 14,844, 7,664, and 24,222 shares with grant dates of 07/30/2023, 11/09/2023, and 05/02/2024, respectively.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists proposed resale of common stock tied to prior equity grants.

The filing is a procedural notice that a holder intends to sell restricted or control securities under resale rules. The excerpt shows broker information and three prior Restricted Stock Unit grants with explicit grant dates and share counts.

Timing, exact number of shares being offered for sale, and cash‑flow treatment are not specified in the excerpt; subsequent filings or a complete Form 144 would show the specific sale quantities and methods.

Form filing date 04/15/2026 Form 144 header
RSU grant (07/30/2023) 14,844 shares Restricted Stock Unit Grant dated 07/30/2023
RSU grant (11/09/2023) 7,664 shares Restricted Stock Unit Grant dated 11/09/2023
RSU grant (05/02/2024) 24,222 shares Restricted Stock Unit Grant dated 05/02/2024
Restricted Stock Unit financial
"Restricted Stock Unit Grant | Maplight Therapeutics, Inc."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Form 144 regulatory
"form_type: "144" in metadata and header lines"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Jefferies other
"Jefferies 520 Madison Ave New York NY 10022"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Maplight Therapeutics (MPLT) Form 144 mean?

It signals a notice of an intended resale of restricted or control securities under Rule 144. The excerpt lists broker details and grant history but does not state exact sale quantities or proceeds.

Which securities are listed in the MPLT excerpt?

The excerpt lists Common stock tied to Restricted Stock Unit grants. Grant counts shown are 14,844; 7,664; and 24,222 shares on the listed grant dates.

When was the Form 144 filing date shown for MPLT?

The filing date shown in the excerpt is 04/15/2026. The excerpt does not include closing or settlement dates for any sale activity.

Does this excerpt state how many shares will be sold for MPLT?

No. The excerpt lists prior RSU grant counts and dates but does not specify the number of shares proposed for sale or the sale method in this excerpt.